The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126006091 12600609 1 I 2010 20160719 20160727 20160727 EXP US-ASTRAZENECA-2016SE79254 ASTRAZENECA 82.00 YR F Y 90.70000 KG 20160727 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126006091 12600609 1 PS ARIMIDEX ANASTROZOLE 1 Oral 2557 MG 20541 1 MG TABLET QD
126006091 12600609 2 SS PULMICORT FLEXHALER BUDESONIDE 1 Respiratory (inhalation) 90 UG, TWO PUFFS, TWO TIMES A DAY N U 0 INHALATION POWDER
126006091 12600609 3 C ENALAPRIL ENALAPRIL 1 Oral 0 2.5 MG BID
126006091 12600609 4 C COREG CARVEDILOL 1 Oral 0 6.25 MG BID
126006091 12600609 5 C POTASSIUM CHLORIDE. POTASSIUM CHLORIDE 1 Oral 0 10 MEQ BID
126006091 12600609 6 C PLAVIX CLOPIDOGREL BISULFATE 1 Oral 0 75 MG QD
126006091 12600609 7 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 Oral 0 75 MG QD
126006091 12600609 8 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 0 20 MG QD
126006091 12600609 9 C MIRAPEX ER PRAMIPEXOLE DIHYDROCHLORIDE 1 Oral 0 2.5 MG QD
126006091 12600609 10 C THERACRAN 2 Oral TWICE DAILY 0
126006091 12600609 11 C VITAMIN D CHOLECALCIFEROL 1 Oral 0 1000 IU QD
126006091 12600609 12 C EYE CAPS-PRESERVISION AREDS NO. 2 2 Oral 1 TAB TWICE DAILY 0
126006091 12600609 13 C SANTURA TRIPODIUM CHLORIDE 2 0 20 MG QD
126006091 12600609 14 C LEVADOPA 2 Oral 25/100 GIVE 1??? TABS THREE TIMES DAILY 0
126006091 12600609 15 C REMERON MIRTAZAPINE 1 Oral 0 15 MG QD
126006091 12600609 16 C REMERON MIRTAZAPINE 1 Oral 0 15 MG QD
126006091 12600609 17 C TESSALON BENZONONATE 2 Oral 100 MG, THREE TIMES A DAY AND ADDITIONAL 3 TIMES PER DAY AS NEEDED 0
126006091 12600609 18 C CHLORATRIMITON 2 Oral AS NEEDED FOR DECADES 0
126006091 12600609 19 C TYLENOL ACETAMINOPHEN 1 Oral AS NEEDED 0
126006091 12600609 20 C DORZOLMIDE-TIMOLOL 2 Ophthalmic EYE DROPS 1 DROP IN RIGHT EYE TWICE DAILY 0
126006091 12600609 21 C LATANOPROST. LATANOPROST 1 Ophthalmic 0.005% 1 DROP IN RIGHT EYE NIGHTLY 0 1 GTT EYE DROPS QD
126006091 12600609 22 C ALPHAGAN P BRIMONIDINE TARTRATE 1 Ophthalmic 1 DROP IN RIGHT EYE DAILY 0 EYE DROPS
126006091 12600609 23 C XELANTAN 2 Ophthalmic IN RIGHT EYE 0 EYE DROPS
126006091 12600609 24 C TIMOLOL. TIMOLOL 1 Ophthalmic IN LEFT EYE 0 EYE DROPS
126006091 12600609 25 C HUMALOG INSULIN LISPRO 1 Subcutaneous 8 INTERNATIONAL UNITS SUBQ TWICE DAILY WITH BREAKFAST AND LUNCH 0
126006091 12600609 26 C HUMALOG INSULIN LISPRO 1 Subcutaneous 10 INTERNATIONAL UNITS SUBQ WITH DINNER 0
126006091 12600609 27 C LANTUS INSULIN GLARGINE 1 Subcutaneous 34 INTERNATIONAL UNITS SUBQ AT 11:00 PM NIGHTLY 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126006091 12600609 1 Neoplasm malignant
126006091 12600609 2 Asthma
126006091 12600609 3 Cardiac failure congestive
126006091 12600609 4 Cardiac disorder
126006091 12600609 6 Stent placement
126006091 12600609 7 Hot flush
126006091 12600609 8 Blood cholesterol abnormal
126006091 12600609 9 Parkinson's disease
126006091 12600609 10 Cystitis
126006091 12600609 12 Vitamin supplementation
126006091 12600609 13 Incontinence
126006091 12600609 14 Parkinson's disease
126006091 12600609 15 Antidepressant therapy
126006091 12600609 16 Insomnia
126006091 12600609 17 Cough
126006091 12600609 18 Antiallergic therapy
126006091 12600609 20 Eye disorder
126006091 12600609 21 Eye disorder
126006091 12600609 22 Eye disorder
126006091 12600609 23 Eye disorder
126006091 12600609 24 Eye disorder

Outcome of event

Event ID CASEID OUTC COD
126006091 12600609 OT
126006091 12600609 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126006091 12600609 Asthma
126006091 12600609 Bladder cancer
126006091 12600609 Breast cancer
126006091 12600609 Diabetes mellitus
126006091 12600609 Glaucoma
126006091 12600609 Hypersensitivity
126006091 12600609 Intestinal obstruction
126006091 12600609 Intraocular pressure increased
126006091 12600609 Large intestine perforation
126006091 12600609 Malaise
126006091 12600609 Parkinson's disease

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126006091 12600609 1 2009 0
126006091 12600609 2 201604 201607 0
126006091 12600609 3 201404 0
126006091 12600609 4 201404 0
126006091 12600609 5 201404 0
126006091 12600609 6 201404 0
126006091 12600609 7 2010 0
126006091 12600609 12 2013 0
126006091 12600609 13 2006 0
126006091 12600609 14 2014 0
126006091 12600609 15 2015 0
126006091 12600609 16 2015 0
126006091 12600609 17 2015 0
126006091 12600609 20 2013 0
126006091 12600609 21 2013 0
126006091 12600609 22 201605 0
126006091 12600609 23 201605 0
126006091 12600609 24 201605 0